H. Heynemann

Interleukin-2- and Interferon Alfa-2a-Based Immunochemotherapy in Advanced Renal Cell Carcinoma: A Prospectively Randomized Trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN)

Jens Atzpodien, Hartmut Kirchner, Udo Jonas et al. · Journal of Clinical Oncology · 2004 · 225 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Adjuvant treatment with interleukin-2- and interferon-alpha2a-based chemoimmunotherapy in renal cell carcinoma post tumour nephrectomy: Results of a prospectively randomised Trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN)

Jens Atzpodien, E. Schmitt, Ulrich Gertenbach et al. · British Journal of Cancer · 2005 · 184 citations · Full text

Medicine, Immunology, Oncology +14

Detection and enrichment of disseminated renal carcinoma cells from peripheral blood by immunomagnetic cell separation

Udo Bilkenroth, Helge Täubert, Dagmar Riemann et al. · International Journal of Cancer · 2001 · 89 citations

Medicine, Cell Biology, Oncology +17

Detection of Circulating Tumor Cells in Peripheral Blood of Patients with Renal Cell Carcinoma Correlates with Prognosis

Karen Bluemke, Udo Bilkenroth, Axel Meye et al. · Cancer Epidemiology Biomarkers & Prevention · 2009 · 82 citations

Medicine, Oncology, Pathology +17

Endopeptidase 24.11/CD10 is down-regulated in renal cell cancer.

Barbara Göhring, H.-J. Holzhausen, Axel Meye et al. · International Journal of Molecular Medicine · 1998 · 55 citations

Medicine, Cancer Biology, Molecular Biology +17